Patients (N = 973) | ||||||||
---|---|---|---|---|---|---|---|---|
Failure mode | Local No. (%) | p | Regional No. (%) | p | Local or Regionala No. (%) | p | Distant | p |
Low-risk (N = 284) | 0.215 | 0.536 | 0.666 | 0.195 | ||||
VBT alone (N = 189) | 1 (0.5) | 3 (1.6) | 3 (1.6) | 6 (3.2) | ||||
EBRT (with or without VBT) (N = 95) | 3 (3.2) | 0 (0.0) | 3 (3.2) | 7 (7.4) | ||||
Intermediate risk-risk (N = 290) | 0.990 | 0.605 | 0.433 | 0.796 | ||||
VBT alone (N = 146) | 1 (0.7) | 1 (0.7) | 2 (1.4) | 7 (4.8) | ||||
EBRT (with or without VBT) (N = 144) | 2 (1.4) | 3 (2.1) | 5 (3.5) | 6 (4.2) | ||||
High-intermediate-risk (N = 185) | 1.000 | 0.377 | 0.249 | 0.639 | ||||
VBT alone (N = 99) | 2 (2.0) | 6 (6.1) | 7 (7.1) | 6 (6.1) | ||||
EBRT (with or without VBT) (N = 86) | 1 (1.2) | 2 (2.3) | 2 (2.3) | 3 (3.5) | ||||
High-risk (N = 214) | 0.218 | 0.178 | 0.016 | 0.147 | ||||
VBT alone (N = 24) | 1 (4.2) | 2 (8.3) | 7 (7.1) | 5 (20.8) | ||||
EBRT (with or without VBT) (N = 190) | 0 (0.0) | 3 (1.6) | 2 (2.3) | 17 (8.9) |